Publications by authors named "Denis Fiere"

Claim this Profile
C
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Oumedaly Reman, Arnaud Pigneux, Françoise Huguet, Norbert Vey, André Delannoy

Leuk Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
Quoc-Hung Le, Xavier Thomas, René Ecochard, Jean Iwaz, Véronique Lhéritier, Denis Fiere

Cancer· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial and late prognostic factors to predict survival in adult acute lymphoblastic leukaemia.
Quoc-Hung Le, Xavier Thomas, René Ecochard, Jean Iwaz, Véronique Lhéritier, Denis Fiere

Eur J Haematol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.
Vahid Asnafi, Agnes Buzyn, Xavier Thomas, Francoise Huguet, Norbert Vey, Denis Fiere

Blood· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
Xavier Thomas, Jean-Michel Boiron, Françoise Huguet, Oumedaly Reman, Laurent Sutton, Denis Fiere

Hematol J· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.
Oumedaly Reman, Agnes Buzyn, Veronique Lhéritier, Francoise Huguet, Mathieu Kuentz

Hematol J· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL).
Christiane Charrin, Xavier Thomas, Martine Ffrench, Quoc-Hung Le, Joris Andrieux

Blood· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
Xavier Thomas, Jean-Michel Boiron, Françoise Huguet, Hervé Dombret, Ken Bradstock, Denis Fiere

J Clin Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features.
Christiane Charrin, Amine Belhabri, Danielle Treille-Ritouet, Gianina Theuil, Jean-Pierre Magaud, Denis Fiere

Hematol J· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.
Amine Belhabri, Xavier Thomas, Eric Wattel, Youcef Chelghoum, Bruno Anglaret

Hematol J· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Jacques Delaunay, Norbert Vey, Thierry Leblanc, Pierre Fenaux, Françoise Rigal-Huguet

Blood· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
Cécile Vigneau, Claude Ardiet, Monique Bret, Maurice Laville, Denis Fiere

J Nephrol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Nicolas Boissel, Marie-Françoise Auclerc, Véronique Lhéritier, Yves Perel, Xavier Thomas

J Clin Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.
Hervé Dombret, Jean Gabert, Jean-Michel Boiron, Françoise Rigal-Huguet, Didier Blaise

Blood· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
Hans D Menssen, Adriana Sakalová, Aurélie Fontana, Zuzana Herrmann, Christian Boewer, Denis Fiere

J Clin Oncol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
Stéphanie Nguyen, Thierry Leblanc, Pierre Fenaux, Francis Witz, Didier Blaise

Blood· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis